Search results
Results from the WOW.Com Content Network
Opioid agonist therapy. Opioid agonist therapy (OAT) is a treatment in which prescribed opioid agonists are given to patients who live with Opioid use disorder (OUD). [1] In the case of methadone maintenance treatment (MMT), methadone is used to treat dependence on heroin or other opioids, and is administered on an ongoing basis. [2]
Opioid use disorder (OUD) is a substance use disorder characterized by cravings for opioids, continued use despite physical and/or psychological deterioration, increased tolerance with use, and withdrawal symptoms after discontinuing opioids. [12] Opioid withdrawal symptoms include nausea, muscle aches, diarrhea, trouble sleeping, agitation ...
Opioid-induced endocrinopathy. Opioid-induced endocrinopathy (OIE) is a complication of chronic opioid treatment. [1] [2] [3] It is a common name for all hypothalamo-pituitary axis disorders, which can be observed mostly after long term use of opioids, both as a treatment and as a substance of abuse. [1]
Drug rehabilitation is the process of medical or psychotherapeutic treatment for dependency on psychoactive substances such as alcohol, prescription drugs, and street drugs such as cannabis, cocaine, heroin, and amphetamines.
Clinical Opioid Withdrawal Scale more commonly known as COWS is a method used to measure opioid withdrawal symptoms for both inpatients and outpatients. This intricate scaling system allows the analysis of patient condition. Each question in this test provides the opportunity for the practitioner to identify the severity and the type of opioid ...
Opioid withdrawal. Suboxone tablet (Buprenorphine / naloxone) delivers the opioid drug through a sublingual route, giving fast onset of effects. Opioid withdrawal is a set of symptoms (a syndrome) arising from the sudden withdrawal or reduction of opioids where previous usage has been heavy and prolonged. [1][2] Signs and symptoms of withdrawal ...
Treatment Improvement Protocols (TIPs) are a series of best-practice manuals for the treatment of substance use and other related disorders. The TIP series is published by the Substance Abuse and Mental Health Services Administration (SAMHSA), an operational division of the U.S. Department of Health and Human Services.
The United States Centers for Disease Control and Prevention has data on drug overdose death rates and totals. Around 1,106,900 US residents died from drug overdoses from 1968 to 2020, around 932,400 from 1999 through 2020 and around 93,700 in 2020. Of every 100,000 people in 2020 in the US, drugs killed 28.